文献速递心境障碍焦虑、强迫与应激相关障碍会诊联络精神医学

精神病学中建立临床决策阈值的策略:一篇综述

Strategies for Establishing Clinical-Decision Thresholds in Psychiatry: A Review.
PubMed 文献 · JAMA Psychiatry · 2026-01-01

本综述指出精神病理学本质上是连续的,但临床与研究常需分类决策,因此需对连续现象应用阈值。文章评估了四种建立精神病学维度阈值的策略:基于统计偏离定义多重阈值、参照功能损害、参照负性结局概率、基于临床行动的成本与收益。结论认为诊断聚焦的阈值虽有价值,但应同时考虑上述替代策略,且这些方法在精神病学中应用严重不足,亟需研究。

要点

  • 精神病理学维度本质连续,分类决策需阈值,但仅聚焦诊断的阈值在许多决策中可能无益。
  • 四种替代策略:统计偏离多重阈值、功能损害参照、负性结局概率参照、成本收益参照。
  • 策略2、3、4含价值判断,需利益相关者参与;阈值仅为临床决策因素之一。

核心结论

  • 诊断聚焦的阈值有时有价值,但领域最佳发展应同时考虑基于统计偏离、功能损害、负性结局概率及成本收益的替代策略。
  • 这些替代策略在精神病学中应用严重不足,亟需研究填补空白,文中提供了相关研究建议。

研究设计与样本

  • 综述,借鉴精神病学、心理学、内科和卫生经济学中使用的阈值开发方法。

主要发现

  • 策略一:在神经心理学、儿童精神病学、临床心理学和检验医学中广泛使用,基于与一般人群的统计偏离定义多重阈值(如轻、中、重度)。
  • 策略二:参照功能损害选择阈值,已用于某些精神病理学测量。
  • 策略三:参照负性结局(如死亡率)概率,在内科常见但精神病学中应用不足。
  • 策略四:基于不同严重程度或风险水平下临床行动的成本与收益选择阈值,在欧洲精神病学中势头渐增。

关键数值与推荐

  • 四种策略均不仅适用于临床测量,也适用于研究工具。
  • 策略2、3、4固有价值判断,阈值选择需利益相关者输入。
  • 临床医生决策时考虑所有信息,阈值仅为其中一个因素。

临床怎么用

  • 临床决策中不应仅依赖诊断性阈值,可结合功能损害、负性结局概率及成本收益等多维度阈值。
  • 选择阈值时需纳入利益相关者价值判断,并认识到阈值仅为决策因素之一。

局限性

  • 原文未报告综述的检索范围、纳入研究数量或具体局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Nearly all psychopathology is inherently continuous, but both clinical practice and research often require categorical decisions (eg, treat or wait, pay for treatment or decline, enroll in study or not); therefore, thresholds are applied to continuous phenomena to guide these decisions. The most common strategy is to select cutoffs by focusing on diagnoses, but this may be unhelpful in many decisions (eg, selective prevention, choice between treatment options). This review evaluates strategies for developing thresholds for psychopathology dimensions that may enhance clinical decision-making, drawing on methods used in psychiatry, psychology, internal medicine, and health economics. OBSERVATIONS: One strategy used extensively in neuropsychology, child psychiatry, clinical psychology, and laboratory medicine is to define multiple thresholds (eg, mild, moderate, and severe), using statistical deviance vis-à-vis the general population. A second strategy is to select thresholds in reference to functional impairment, as has been done for some psychopathology measures. A third approach, common in internal medicine but underused in psychiatry, references probability of a negative outcome (eg, mortality). A fourth option, gaining momentum in European psychiatry, is to select thresholds based on costs and benefits of a clinical action at different levels of severity or risk. Common examples of these 4 strategies are reviewed, comparing their strengths and limitations. They are relevant not only to clinical measures but also research instruments. Value judgments are inherent in approaches 2, 3, and 4; thus, selection of such thresholds requires stakeholder input. Importantly, clinicians make decisions by considering all information, and thresholds are only 1 factor. CONCLUSIONS AND RELEVANCE: Although diagnosis-focused thresholds are sometimes valuable, the field would be served best by also considering the aforementioned alternative strategies. These approaches have been greatly underused in psychiatry, and studies are urgently needed to address this gap. Herein, recommendations are offered for this research.

来源:JAMA Psychiatry,查看原文。版权归原作者所有。

引用

  1. Kotelnikova Y, Clark LA, Ruggero CJ, et al. Strategies for Establishing Clinical-Decision Thresholds in Psychiatry: A Review. JAMA Psychiatry. 2026. PMID: 42201715. doi:10.1001/jamapsychiatry.2026.1078

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。